Recent press releases

June 22, 2017

FDA approves first subcutaneous C1 Esterase Inhibitor to treat rare genetic disease

May 24, 2017

Attune Pharmaceuticals Announces Positive Data from Recent Pre-Clinical Studies for ATN-249, an Oral Plasma Kallikrein Inhibitor for the Treatment of HAE at C1-INH Deficiency Workshop

May 24, 2017

Shire’s Investigational Treatment Lanadelumab Reduces Hereditary Angioedema Monthly Attack Rate by 87% Versus Placebo in Phase 3 26-week Pivotal Trial

April 13, 2017

BioCryst Expands Development of BCX7353 to Explore Treatment of Acute HAE Attacks

WHO WE ARE

The US HAEA is a non-profit patient advocacy organization dedicated to serving persons with angioedema.
We provide patients and families with a support network and wide range of services.

WE ARE
  • PATIENTS
  • CAREGIVERS
  • UNBIASED
  • RELIABLE
  • HERE FOR YOU
  • HAE.

Press contact


Janet Long
Executive Vice President
Contact Janet Long

HAEA on social media

                  

Post your HAE related content with our shared tags
#haea
#wearehae
#raredisease

Download

 

Jump to our sections with comprehensive content and learn more

null

What is HAE

Get to know the disease: symptoms, diagnose, treatments and more

Take me there >

Professionals

For healthcare providers. Knowledge, CME-programs and more

Take me there >

Living with HAE

Care takers and givers: HAE will affect your life - But you can still be in control.

Take me there >

Resources

Our area with a lot of usefull information

Take me there >